Literature DB >> 6273765

Sjögren syndrome: central nervous system manifestations.

G E Alexander, T T Provost, M B Stevens, E L Alexander.   

Abstract

We studied eight patients who had primary Sjögren syndrome and central nervous system (CNS) disorders that were not attributable to other causes. Focal cerebral deficits were observed in five patients. Aseptic meningoencephalitis was seen in five patients, recurrent in one. Spinal cord manifestations in three patients took several forms: acute transverse myelitis, chronic progressive myelopathy, and spinal subarachnoid hemorrhage. Precipitating antibodies to the Ro(SSA) cytoplasmic antigen were detected in the sera of seven of eight patients. This may be relevant to the pathogenesis of CNS disease in Sjögren syndrome, because there is a strong correlation between vasculitis and the presence of anti-Ro(SSA) antibodies in this connective tissue disorder.

Entities:  

Mesh:

Year:  1981        PMID: 6273765     DOI: 10.1212/wnl.31.11.1391

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  CNS involvement in primary Sjögren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach.

Authors:  M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndrome.

Authors:  P J Barendregt; A H van Den Meiracker; H M Markusse; J H Tulen; F Boomsma; G L van Der Heijde; A J Veld
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

3.  Hypertrophic neuropathy in Sjögren;s syndrome.

Authors:  A Marbini; F Gemignani; P Manganelli; E Govoni; M M Bragaglia; U Ambanelli
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Peripheral neuropathy associated with the sicca syndrome.

Authors:  R P Kennett; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

Review 5.  [Vasculopathy in Sjögren's syndrome].

Authors:  E Feist; K-G A Hermann; A Dankof
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

6.  Astasia-abasia revealing a primary Sjögren's syndrome.

Authors:  P Lafforgue; E Toussirot; F Billé; P C Acquaviva
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

7.  Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.

Authors:  Waka Yokoyama; Kazuki Takada; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  BMJ Case Rep       Date:  2014-08-01

Review 8.  Demyelination in rheumatic diseases.

Authors:  A Theodoridou; L Settas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

9.  Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder.

Authors:  Yuichiro Ii; Akihiro Shindo; Ryogen Sasaki; Yutaka Naito; Keiko Tanaka; Shigeki Kuzuhara
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

Review 10.  Myelopathy in Sjögren's syndrome: role of nonsteroidal immunosuppressants.

Authors:  Susan J Rogers; Christopher S Williams; Gustavo C Román
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.